Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Regulatory News (GWP)

  • There is currently no data for GWP

Director/PDMR Shareholding

4 Dec 2012 10:04

RNS Number : 6763S
GW Pharmaceuticals PLC
04 December 2012
 

GW Pharmaceuticals PLC Director/PDMR Shareholding

4 December 2012

GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

Porton Down, UK, 4 December 2012: GW Pharmaceuticals (AIM: GWP) hereby provides notification that on 3rd December Chris Tovey, Chief Operations Officer of the Company, purchased 5,000 0.1 pence ordinary shares of GW Pharmaceuticals plc at a purchase price of 63.5 pence per share.

Following this notification Mr Tovey has a total beneficial interest in 5,000 GW Pharmaceuticals plc ordinary shares of 0.1 pence each, representing less than 0.1% of the Company's current issued share capital.

The total number of shares outstanding in the Company is 133,370,354 ordinary shares of 0.1 pence each.

Enquiries:

GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000

Adam George, Company Secretary

Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900

James Steel/Vijay Barathan

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIIFFLSIIF
Date   Source Headline
5th Mar 200710:12 amRNSDirector/PDMR Shareholding
28th Feb 20077:00 amRNSSativex Data Update
14th Feb 20077:01 amRNSAlliance with Otsuka
13th Feb 20079:53 amRNSResponse to speculation
30th Jan 20077:01 amRNSFinal Results
26th Jan 20077:00 amRNSBoard Appointment
24th Jan 20073:18 pmRNSHolding(s) in Company
17th Jan 20074:11 pmRNSTotal Voting Rights
15th Jan 20073:01 pmRNSNotice of Results
15th Jan 20077:01 amRNSResearch Update
18th Dec 20062:03 pmRNSTotal Voting Rights
26th Oct 20065:29 pmRNSBlocklisting Interim Review
19th Oct 20067:00 amRNSRegulatory Application
3rd Oct 20067:01 amRNSResearch Update
28th Sep 20067:00 amRNSSite Visit
5th Sep 20067:00 amRNSSativex filing
9th Aug 20067:00 amRNSResearch Update
21st Jul 20064:17 pmRNSDirector/PDMR Shareholding
20th Jun 20067:01 amRNSInterim Results
25th May 20061:37 pmRNSNotice of Results and R&D Day
19th May 20065:20 pmRNSDirector/PDMR Shareholding
16th May 20064:19 pmRNSHolding(s) in Company
16th May 20067:00 amRNSAppointment of Adviser
27th Apr 200612:45 pmRNSBlocklisting Interim Review
24th Mar 20063:33 pmRNSDirector/PDMR Shareholding
21st Mar 20062:36 pmRNSAGM Statement
17th Mar 20067:03 amRNSResearch Update
13th Feb 20067:01 amRNSGrant of Share Options
19th Jan 20067:01 amRNSFinal Results
11th Jan 20064:11 pmRNSHolding(s) in Company
4th Jan 200612:39 pmRNSAdditional Listing
4th Jan 20067:03 amRNSUS Placing
4th Jan 20067:00 amRNSFDA Accepts IND Application
16th Dec 20053:14 pmRNSRe Inquest Verdict
14th Dec 200510:20 amRNSNotice of Results
12th Dec 20057:01 amRNSMarketing Agreement
15th Nov 20057:02 amRNSRe Sativex Update
11th Nov 20053:22 pmRNSBlocklisting Interim Review
9th Nov 20057:01 amRNSSativex - Peer Review
8th Nov 20057:02 amRNSSativex - Supplied in Spain
27th Sep 20057:04 amRNSSativex - Peer Review
1st Sep 200511:14 amRNSAdditional Listing
21st Jul 20053:28 pmRNSAdditional Listing
20th Jun 20057:02 amRNSSativex Launch Canada
20th Jun 20057:01 amRNSInterim Results
10th Jun 20057:00 amRNSUK Regulatory Update
6th Jun 20056:19 pmRNSStatement re. Press Comment
1st Jun 20053:26 pmRNSHolding(s) in Company
26th May 20052:49 pmRNSNotice of Results
11th May 20057:00 amRNSRe Marketing Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.